InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2024-05-24 00:00:00 ET · period of report 2024-05-22 · accession 0001438133-24-000126 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-24 2024-05-24 TNDM Howell Peyton R Dir M - OptEx $51.73 +4,434 16.7K +36% +$229.4K
D 2024-05-24 2024-05-22 TNDM Howell Peyton R Dir A - Grant $0.00 +4,387 4,387 New $0
D 2024-05-24 2024-05-24 TNDM Howell Peyton R Dir M - OptEx $0.00 -4,434 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-24 M A 4,434 $51.73 16,690 D — —
2 Derivative Restricted Stock Unit 2024-05-22 A A 4,387 $0.00 4,387 D — · — to — 4,387 Common Stock (F1) Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). (F2) Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F3) RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
3 Derivative Restricted Stock Unit 2024-05-24 M D 4,434 $0.00 0 D — · — to — 4,434 Common Stock (F4) Awarded on May 24, 2023 pursuant to the 2023 Plan. (F2) Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. (F3) RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.